Last Updated on March 18, 2024 by The Health Master
1. USFDA
In a groundbreaking development, Torrent Pharma, a prominent Indian multinational pharmaceutical company headquartered in Ahmedabad, proudly announces the issuance of the Establishment Inspection Report (EIR) by the US Food and Drug Administration (USFDA) for its Oral-Oncology manufacturing facility located in Bileshwarpura, Gujarat.
2. Background of Torrent Pharma
Before delving into the recent success, let’s understand Torrent Pharma‘s background.
Established in Ahmedabad, India, the company has carved a niche in the pharmaceutical industry, specializing in cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI), and women healthcare (WHC) segments.
3. The USFDA Inspection Journey
The journey began with the USFDA conducting a Pre-Approval Inspection (PAI) at the Oral-Oncology manufacturing facility.
This inspection aimed to ensure compliance with regulatory standards and procedures.
4. Pre-Approval Inspection (PAI) Findings
During the PAI, the USFDA identified five procedural observations at the Bileshwarpura facility.
These observations are crucial checkpoints in the approval process, requiring meticulous attention and resolution.
5. Addressing Procedural Observations
Torrent Pharma, demonstrating its commitment to quality and compliance, promptly addressed the procedural observations raised by the USFDA.
The company undertook corrective measures to rectify any deviations from established protocols.
6. Successful Closure of Inspection
The relentless efforts of Torrent Pharma‘s team culminated in the successful closure of the USFDA inspection.
The issuance of the Establishment Inspection Report (EIR) signifies the acknowledgment of compliance and adherence to regulatory standards.
7. Significance for Torrent Pharma
This achievement holds immense significance for Torrent Pharma, as it reflects the company’s dedication to maintaining the highest standards of quality and regulatory compliance.
The successful inspection enhances Torrent Pharma’s reputation as a reliable and compliant pharmaceutical manufacturer.
8. Oral-Oncology Manufacturing Facility Overview
To comprehend the magnitude of this success, let’s delve into the specifics of the Oral-Oncology manufacturing facility in Bileshwarpura, Gujarat.
9. Location: Bileshwarpura, Gujarat
Situated in the vibrant state of Gujarat, the Bileshwarpura facility stands as a testament to Torrent Pharma’s strategic positioning in one of India’s pharmaceutical hubs.
10. Understanding the Establishment Inspection Report (EIR)
The EIR serves as a comprehensive report by the USFDA, detailing the findings and conclusions of the inspection. It provides insights into the facility’s compliance with regulatory requirements.
11. Regulatory Compliance and Pharmaceutical Industry
In the pharmaceutical industry, regulatory compliance is paramount.
The stringent standards set by regulatory bodies ensure the safety, efficacy, and quality of pharmaceutical products, fostering trust among consumers and healthcare professionals.
12. Torrent Pharma’s Specialization
Torrent Pharma’s specialization in cardiovascular, central nervous system, gastro-intestinal, and women healthcare segments positions it as a versatile player in the pharmaceutical landscape.
13. Therapeutic Segments
The company’s focus on therapeutic segments reflects its commitment to addressing diverse medical needs.
Cardiovascular, central nervous system, gastro-intestinal, and women healthcare represent critical areas in healthcare.
14. Future Implications
With the successful closure of the USFDA inspection, Torrent Pharma opens new doors for future growth.
The positive outcome is likely to have far-reaching implications for the company’s expansion and collaboration prospects.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
Aurobindo Pharma’s Arm gets 7 observations from USFDA
USFDA’s Agenda for Indian Pharma Industry
Telangana Drug Inspectors Now Eligible to Observe USFDA Inspections
USFDA grants VAI classification to Dr Reddy’s R&D centre
The Delhi High Court’s Deadline: For Online Drug Sales
USFDA Approval granted for Gabapentin Tablets: Strides
NPPA fixed Ceiling price of 6 scheduled formulations: February 2024
IPC releases draft guidelines to include Disinfectants & Antiseptics in IP
No More Discount Banners for Pharmacies in Maharashtra
Aurobindo Pharma’s Arm gets 7 observations from USFDA
NPPA revised Ceiling price of 25 scheduled formulations: February 2024
Pharma Transparency: The Need for Clearer Eye Drops Packaging
A Critical Analysis of latest Homoeopathy Notification No. GSR 98(E) dated 02-02-2024
CDSCO’s Revised Guidance on Post Approval Changes in Biological Products
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
